Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lapatinib in ER+/PR+ HER2- Metastatic Breast Cancer
NCT00759642Phase 2Terminated
- Sponsor
- University of Kansas Medical Center
- Start
- Mar 2009
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in breast cancer, sponsored by University of Kansas Medical Center. Started Mar 2009; status: terminated.
02
Drugs
lapatinib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00759642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00759642.